| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers E > Headlines for Eiger BioPharmaceuticals, Inc. > News item |
Eiger BioPharmaceuticals to offer up to $25 million common stock
Cantor Fitzgerald is agent for at-the-market offerings
By Marisa Wong
Morgantown, W.Va., June 23 – Eiger BioPharmaceuticals, Inc. entered into an agreement on June 17 to sell up to $25 million of common stock through at-the-market offerings, according to an 8-K filing with the Securities and Exchange Commission.
Cantor Fitzgerald & Co. is the agent.
The company will pay Cantor Fitzgerald a commission of 3% for each sale.
The biopharmaceutical company is based in Palo Alto, Calif.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.